Skip to content
zameds

Dasatinib

Sold as Sprycel, Dasatinib eurolab, Dasatinib teva, Tazatred, Dasamia, Dasacord

S4
Loading the molecular structure
C22H26ClN7O2S488.00 g/mol

N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide

Drag to rotate. Structure from PubChem CID 3062316.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
6
Registrations
26
Schedule source
Consolidated Schedules 06 July 2026

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Equity Pharmaceutical (Pty) LtdSprycel20 mg, 50 mg, 70 mg, 100 mg411039, 411040, 411041, 440205S4None
Eurolab (Pty) LtdDasatinib eurolab20, 50, 70, 80, 100550397, 550398, 550399, 550400, 550401S4None
Teva Pharmaceuticals (Pty) LtdDasatinib teva20, 50, 100550448, 550449, 550451S4PIPIL
Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr Reddy's Laboratories (Pty) LtdTazatred20, 50, 70, 100550797, 550798, 550799, 550800S4PIPIL
Ranbaxy Pharmaceutical (Pty) LtdDasamia20, 50, 70, 100560207, 560208, 560209, 560210S4None
Accord Healthcare (Pty) LtdDasacord20 mg, 50 mg, 70 mg, 80 mg, 100 mg, 140 mg590443, 590444, 590445, 590446, 590447, 590448S4None

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Sprycel 20 MG tablets

EACH TABLET CONTAINS DASATINIB 20,0 mg

20 mgTablets41103941/26/1039RegisteredS4None
Sprycel 50 MG tablets

EACH TABLET CONTAINS DASATINIB 50,0 mg

50 mgTablets41104041/26/1040RegisteredS4None
Sprycel 70 MG tablets

EACH TABLET CONTAINS DASATINIB 70,0 mg

70 mgTablets41104141/26/1041RegisteredS4None
Sprycel 100 MG tablets

EACH TABLET CONTAINS DASATINIB 100,0 mg

100 mgTablets44020544/26/0205RegisteredS4None
Dasatinib 20 eurolab

EACH TABLET CONTAINS DASATINIB 20,0 mg

2055039755/26/0397RegisteredS4None
Dasatinib 50 eurolab

EACH TABLET CONTAINS DASATINIB 50,0 mg

5055039855/26/0398RegisteredS4None
Dasatinib 70 eurolab

EACH TABLET CONTAINS DASATINIB 70,0 mg

7055039955/26/0399RegisteredS4None
Dasatinib 80 eurolab

EACH TABLET CONTAINS DASATINIB 80,0 mg

8055040055/26/0400RegisteredS4None
Dasatinib 100 eurolab

EACH TABLET CONTAINS DASATINIB 100,0 mg

10055040155/26/0401RegisteredS4None
Dasatinib 20 teva

DASATINIB MONOHYDRATE

20Film-coated tablets55044855/26/0448Approved 22 November 2024RegisteredS4PIPIL
Dasatinib 50 teva

DASATINIB MONOHYDRATE

50Film-coated tablets55044955/26/0449Approved 22 November 2024RegisteredS4PIPIL
Dasatinib 100 teva

DASATINIB MONOHYDRATE

100Film-coated tablets55045155/26/0451Approved 22 November 2024RegisteredS4PIPIL
Tazatred 20

EACH TABLET CONTAINS DASATINIB 20,0 mg

20Tablet55079755/26/0797Approved 24 March 2023RegisteredS4PIPIL
Tazatred 50

EACH TABLET CONTAINS DASATINIB 50,0 mg

50Tablet55079855/26/0798Approved 24 March 2023RegisteredS4PIPIL
Tazatred 70

EACH TABLET CONTAINS DASATINIB 70,0 mg

70Tablet55079955/26/0799Approved 24 March 2023RegisteredS4PIPIL
Tazatred 100

EACH TABLET CONTAINS DASATINIB 100,0 mg

100Tablet55080055/26/0800Approved 24 March 2023RegisteredS4PIPIL
Dasamia 20

EACH TABLET CONTAINS DASATINIB 20,0 mg

2056020756/26/0207RegisteredS4None
Dasamia 50

EACH TABLET CONTAINS DASATINIB 50,0 mg

5056020856/26/0208RegisteredS4None
Dasamia 70

EACH TABLET CONTAINS DASATINIB 70,0 mg

7056020956/26/0209RegisteredS4None
Dasamia 100

EACH TABLET CONTAINS DASATINIB 100,0 mg

10056021056/26/0210RegisteredS4None
Dasacord 20 MG

EACH TABLET CONTAINS: DASATINIB MONOHYDRATE EQUIVALENT TO DASATINIB 20,0 mg

20 mg59044359/26/0443RegisteredS4None
Dasacord 50 MG

EACH TABLET CONTAINS: DASATINIB MONOHYDRATE EQUIVALENT TO DASATINIB 50,0 mg

50 mg59044459/26/0444RegisteredS4None
Dasacord 70 MG

EACH TABLET CONTAINS: DASATINIB MONOHYDRATE EQUIVALENT TO DASATINIB 70,0 mg

70 mg59044559/26/0445RegisteredS4None
Dasacord 80 MG

EACH TABLET CONTAINS: DASATINIB MONOHYDRATE EQUIVALENT TO DASATINIB 80,0 mg

80 mg59044659/26/0446RegisteredS4None
Dasacord 100 MG

EACH TABLET CONTAINS: DASATINIB MONOHYDRATE EQUIVALENT TO DASATINIB 100,0 mg

100 mg59044759/26/0447RegisteredS4None
Dasacord 140 MG

EACH TABLET CONTAINS: DASATINIB MONOHYDRATE EQUIVALENT TO DASATINIB 150,0 mg

140 mg59044859/26/0448RegisteredS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Dasatinib

  • S4: Dasatinib

    Consolidated Schedules 06 July 2026, line 5958

Pharmacological class: Cytostatic agents (class 26)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Dasatinib 20 teva, Teva Pharmaceuticals (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsDasatinib 20 teva, Teva Pharmaceuticals (Pty) LtdPatient information leaflet (PIL)For patients and carersDasatinib 20 teva, Teva Pharmaceuticals (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles